Alnylam Pharmaceuticals
Develops RNAi therapeutics to treat rare and common diseases.
H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
biotechpharmaceuticals
Company facts
- Founded
- 2002
- Employees
- 2,500
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: ALNY
Open positions
7 jobs
11 hours ago
Director, Clinical Research- Benign Hematology
New North America, UKFull-time Cambridge, MA, Philadelphia, PA, Maidenhead, England
Overview Alnylam Pharmaceuticals is seeking an imaginative physician drug developer, with the flexibility and confidence to work across diseases within the neurology and hematology therapeutic area. This role includes…